Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-CD19 T-cell for B-cell acute lymphoblastic leukemia
TCTR20160921001Phase 2Enrolling by invitation
- Sponsor
- Thailand Center of Excellence for Life Sciences
- Start
- Jun 2017
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Vaccines & Immunotherapeutics, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CT032 in acute lymphoblastic leukemia (ALL), sponsored by Thailand Center of Excellence for Life Sciences. Started Jun 2017; status: enrolling by invitation.
02
Drugs
CT032
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on TCTR20160921001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160921001.